Marino Stram & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.98M | Hold |
5,457
| – | – | 0.31% | 57 |
|
|
2026
Q1 | $1.92M | Buy |
5,457
+58
| +1% | +$20.7K | 0.35% | 53 |
|
|
2025
Q4 | $1.77M | Sell |
5,399
-295
| -5% | -$93.6K | 0.32% | 51 |
|
|
2025
Q3 | $1.61M | Buy |
5,694
+508
| +10% | +$147K | 0.29% | 58 |
|
|
2025
Q2 | $1.45M | Buy |
5,186
+370
| +8% | +$105K | 0.29% | 57 |
|
|
2025
Q1 | $1.5M | Sell |
4,816
-12
| -0.2% | -$3.54K | 0.33% | 49 |
|
|
2024
Q4 | $1.26M | Buy |
4,828
+4
| +0.1% | +$1.19K | 0.28% | 56 |
|
|
2024
Q3 | $1.55M | Buy |
4,824
+31
| +0.6% | +$10.1K | 0.35% | 47 |
|
|
2024
Q2 | $1.5M | Sell |
4,793
-4
| -0.1% | -$1.18K | 0.37% | 45 |
|
|
2024
Q1 | $1.36M | Buy |
4,797
+171
| +4% | +$50K | 0.32% | 48 |
|
|
2023
Q4 | $1.33M | Buy |
4,626
+34
| +0.7% | +$9.26K | 0.34% | 48 |
|
|
2023
Q3 | $1.23M | Buy |
4,592
+92
| +2% | +$23K | 0.36% | 44 |
|
|
2023
Q2 | $999K | Sell |
4,500
-251
| -5% | -$58.2K | 0.28% | 56 |
|
|
2023
Q1 | $1.15M | Buy |
4,751
+381
| +9% | +$93.5K | 0.35% | 47 |
|
|
2022
Q4 | $1.15M | Buy |
4,370
+113
| +3% | +$30.3K | 0.36% | 45 |
|
|
2022
Q3 | $959K | Buy |
4,257
+246
| +6% | +$59.6K | 0.35% | 48 |
|
|
2022
Q2 | $976K | Sell |
4,011
-3
| -0.1% | -$735 | 0.34% | 48 |
|
|
2022
Q1 | $971K | Buy |
4,014
+31
| +0.8% | +$7.12K | 0.31% | 55 |
|
|
2021
Q4 | $896K | Buy |
3,983
+148
| +4% | +$31.2K | 0.28% | 60 |
|
|
2021
Q3 | $816K | Sell |
3,835
-2,912
| -43% | -$670K | 0.28% | 58 |
|
|
2021
Q2 | $1.65M | Buy |
6,747
+3,337
| +98% | +$821K | 0.43% | 62 |
|
|
2021
Q1 | $848K | Buy |
3,410
+362
| +12% | +$86.4K | 0.33% | 52 |
|
|
2020
Q4 | $701K | Buy |
3,048
+304
| +11% | +$70.1K | 0.31% | 48 |
|
|
2020
Q3 | $698K | Buy |
2,744
+124
| +5% | +$30.7K | 0.37% | 47 |
|
|
2020
Q2 | $618K | Buy |
2,620
+784
| +43% | +$179K | 0.37% | 52 |
|
|
2020
Q1 | $372K | Buy |
1,836
+187
| +11% | +$40.8K | 0.29% | 61 |
|
|
2019
Q4 | $398K | Buy |
1,649
+12
| +0.7% | +$2.65K | 0.26% | 61 |
|
|
2019
Q3 | $317K | Hold |
1,637
| – | – | 0.22% | 62 |
|
|
2019
Q2 | $302K | Buy |
1,637
+662
| +68% | +$119K | 0.22% | 65 |
|
|
2019
Q1 | $185K | Buy |
975
+230
| +31% | +$43.9K | 0.13% | 79 |
|
|
2018
Q4 | $175K | Hold |
745
| – | – | 0.15% | 76 |
|
|
2018
Q3 | $154K | Hold |
745
| – | – | 0.12% | 90 |
|
|
2018
Q2 | $138K | Buy |
745
+57
| +8% | +$10.1K | 0.12% | 95 |
|
|
2018
Q1 | $117K | Buy |
688
+155
| +29% | +$28.5K | 0.11% | 110 |
|
|
2017
Q4 | $93K | Buy |
+533
| New | +$94.3K | 0.09% | 122 |
|
Other funds holding AMGN
Marino Stram & Associates's AMGN Position: Q2 2026 in Review
Marino Stram & Associates held its Amgen (AMGN) position steady in Q2 2026 at 5,457 shares worth $1.98M. The position accounts for 0.31% of the portfolio, ranked #57.
Marino Stram & Associates first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. 1,540 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Marino Stram & Associates held 5,457 shares of Amgen worth $1.98M as of Q2 2026.
- Marino Stram & Associates left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.31% of Marino Stram & Associates's portfolio in Q2 2026, its #57 holding.
- Marino Stram & Associates first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- 1,540 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.